Alerts will be sent to your verified email
Verify Email
HESTERBIO
|
Hester Biosciences
|
SMS Pharmaceuticals
|
Bajaj Healthcare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.99 % | 9.06 % | 9.93 % |
|
5yr Avg Net Profit Margin
|
11.57 % | 7.28 % | 3.65 % |
|
Price to Book
|
5.51 | 3.3 | 2.88 |
|
P/E
|
46.1 | 28.83 | 28.5 |
|
5yr Avg Cash Conversion Cycle
|
60.38 Days | 93.25 Days | 15.4 Days |
|
5yr Average Interest Coverage Ratio
|
6.96 | 4.77 | 7.11 |
|
5yr Avg ROCE
|
11.14 % | 12.12 % | 24.2 % |
|
5yr Avg Operating Profit Margin
|
22.71 % | 17.98 % | 16.67 % |
|
5 yr average Debt to Equity
|
0.75 | 0.53 | 0.86 |
|
5yr CAGR Net Profit
|
-4.4 % | 9.56 % | n/a |
|
5yr Average Return on Assets
|
5.28 % | 4.75 % | 5.32 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
53.73 % | 66.26 % | 59.19 % |
|
Share Pledged by Promoters
|
0.0 | 32.49 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 2.09 % | -8.11 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.03 % | 3.03 % | 1.66 % |
|
Hester Biosciences
|
SMS Pharmaceuticals
|
Bajaj Healthcare
|
|---|